reviewTop 10% cited
Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review
Gynecologic Oncology · 2004 · Vol. 95(1) · pp. 133–138
Pedro T. Ramírez✉(The University of Texas MD Anderson Cancer Center)Michael Frumovitz(The University of Texas MD Anderson Cancer Center)Diane C. Bodurka(The University of Texas MD Anderson Cancer Center)Charlotte C. Sun(The University of Texas MD Anderson Cancer Center)Charles Levenback(The University of Texas MD Anderson Cancer Center)
Endometrial and Cervical Cancer TreatmentsOvarian cancer diagnosis and treatmentEndometriosis Research and TreatmentMedicineHormonal therapyGynecologyGeneral surgeryAdenocarcinomaOncologyInternal medicineCancerBreast cancer
MeSH terms
AdultAgedFemaleHumansMiddle AgedNeoplasm StagingProgestinsEndometrial NeoplasmsAntineoplastic Agents, Hormonal
Citations
334
FWCI
10.80
field-weighted impact
References
51
Percentile
99%
vs. same field & year
Citations per year
Cited by
Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic review
Gynecologic Oncology · 2012 · 459 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.